Enanta Pharmaceuticals (ENTA) Q3 2023 Earnings

20NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-2.33
-2
-1.66
-1.33

Details

Expected EPS
-2
Actual EPS
-1.33
Surprise EPS
0.67
Surprise Percent
+33.5%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -1.33 per share for Q3 2023.

0 Comments

Share your thoughts